US-based Becton, Dickinson and Co., (BD) has officially put into operation its new factory in Yixing, Jiangsu province, with an investment worth RMB1.332 billion (USD182.5 million). This plant marks BD’s third world-class local production base in China and is now the central facility for local manufacturing of BD pre-filled flush syringes.
Factory Specifications and Production Capacity
The Yixing factory boasts a total construction area of 35,000 square meters. It is anticipated that upon full construction, the factory will achieve an annual production capacity of 2.5 million liters of bottled injections and an impressive 400 million pre-filled saline syringes.
Enhancing Local Manufacturing Capabilities
This significant investment by BD in its Yixing facility underscores the company’s commitment to enhancing local manufacturing capabilities and meeting the growing demand for high-quality medical products in the Chinese market. The expansion is set to improve supply chain efficiency and responsiveness to market needs, further solidifying BD’s presence in the region.-Fineline Info & Tech
